MedPath

BECONASE NASAL AEM 50MCG/AEM

BECONASE NASAL AEM 50MCG/AEM

Discontinued
DIN Number

01923242

Drug Class

Human

Market Date

Dec 31, 1991

Company
HC

glaxo canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01923242
AIG Number0106320002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R01AD01 BECLOMETHASONE
Product Specifications
Dosage FormMetered-Dose Aerosol
Route of AdministrationNasal
AHFS Classification52:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

BECLOMETHASONE DIPROPIONATEActive
Strength: 50 MCG / ACT
Monograph: BECLOMETHASONE DIPROPIONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.